Literature DB >> 3524743

Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity.

Y Wattanagoon, R E Phillips, D A Warrell, K Silamut, S Looareesuwan, B Nagachinta, D J Back.   

Abstract

In a study of intramuscular injection of quinine eight adults with moderately severe falciparum malaria resistant to chloroquine were treated with quinine dihydrochloride, being given a loading dose of 20 mg salt (16.7 mg base)/kg followed by three or four eight hourly maintenance doses of 10 mg salt (8.3 mg base)/kg injected into the anterior thigh. All patients responded to treatment. Fever and parasite clearance times (mean (SD) 60 (23) h and 53 (22) h respectively) were comparable with those obtained with intravenous quinine. The mean peak plasma quinine concentration of 11.0 mg/l (34.4 mu mol/l) [corrected] was reached a median of five hours after administration of the loading dose. In all patients plasma quinine concentrations exceeded the high minimum inhibitory concentration for Plasmodium falciparum malaria prevalent in Thailand within four hours of the start of treatment but did not cause toxicity other than mild cinchonism. When intravenous infusion is not possible an intramuscular quinine loading dose is an effective means of starting treatment in patients with moderately severe falciparum malaria who cannot swallow tablets.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524743      PMCID: PMC1340765          DOI: 10.1136/bmj.293.6538.11

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  Intramuscular injection of drugs.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

2.  Intramuscular chloroquine in children.

Authors:  P I Trigg; W H Wernsdorfer; U K Sheth; E Onori
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

3.  Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.

Authors:  D J Greenblatt; H J Pfeifer; H R Ochs; K Franke; D S MacLaughlin; T W Smith; J Koch-Weser
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

4.  Intramuscular or intralipomatous injections?

Authors:  W P Cockshott; G T Thompson; L J Howlett; E T Seeley
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

5.  Injectable antimalaria therapy in tropical Africa; iatrogenic disease and waste medical resources.

Authors:  B Guyer; D Candy
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

6.  Quinine disposition kinetics.

Authors:  N J White; P Chanthavanich; S Krishna; C Bunch; K Silamut
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

Review 7.  The treatment of severe falciparum malaria.

Authors:  A P Hall
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

8.  Pharmacokinetics of quinine in children.

Authors:  F Shann; J Stace; M Edstein
Journal:  J Pediatr       Date:  1985-03       Impact factor: 4.406

9.  Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients.

Authors:  D A Warrell; S Looareesuwan; M J Warrell; P Kasemsarn; R Intaraprasert; D Bunnag; T Harinasuta
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

10.  Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; M J Warrell; D Bunnag; T Harinasuta
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

View more
  6 in total

Review 1.  Antimalarial agents: specific treatment regimens.

Authors:  D J Krogstad; B L Herwaldt; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 2.  Diagnosis and treatment of malaria in Britain.

Authors:  M Molyneux; R Fox
Journal:  BMJ       Date:  1993-05-01

3.  Geographical clustering of risk factors and lifestyle for coronary heart disease in the Scottish Heart Health Study.

Authors:  I K Crombie; W C Smith; R Tavendale; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1990-09

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 5.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 6.  Treatment of severe malaria.

Authors:  D A Warrell
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.